Triple
T10268729
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Public Citizen |
E240778
|
entity |
| Predicate | hasOrganizationalUnit |
P254
|
FINISHED |
| Object |
Access to Medicines Program
The Access to Medicines Program is a Public Citizen initiative that advocates for affordable, equitable access to essential medicines worldwide by challenging high drug prices and restrictive pharmaceutical policies.
|
E853090
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Access to Medicines Program | Statement: [Public Citizen, hasOrganizationalUnit, Access to Medicines Program]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Access to Medicines Program Context triple: [Public Citizen, hasOrganizationalUnit, Access to Medicines Program]
-
A.
340B Drug Pricing Program
The 340B Drug Pricing Program is a U.S. federal initiative that requires drug manufacturers to provide outpatient medications to eligible healthcare organizations at significantly reduced prices to support care for underserved patients.
-
B.
World Health Organization Model List of Essential Medicines
The World Health Organization Model List of Essential Medicines is a periodically updated catalog of the most effective, safe, and cost-efficient medicines deemed essential for meeting the priority health needs of populations worldwide.
-
C.
Therapeutics for Rare and Neglected Diseases program
The Therapeutics for Rare and Neglected Diseases program is a U.S. government initiative that accelerates the discovery and development of new treatments for rare and underserved diseases that lack adequate commercial investment.
-
D.
Partners In Health
Partners In Health is a global health and social justice organization that delivers high-quality medical care to impoverished communities around the world and advocates for equitable health systems.
-
E.
Medicaid Drug Rebate Program
The Medicaid Drug Rebate Program is a U.S. federal initiative that requires drug manufacturers to provide rebates to state Medicaid programs in exchange for Medicaid coverage of their outpatient prescription drugs, helping control costs for the program.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Access to Medicines Program Triple: [Public Citizen, hasOrganizationalUnit, Access to Medicines Program]
Generated description
The Access to Medicines Program is a Public Citizen initiative that advocates for affordable, equitable access to essential medicines worldwide by challenging high drug prices and restrictive pharmaceutical policies.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Access to Medicines Program Target entity description: The Access to Medicines Program is a Public Citizen initiative that advocates for affordable, equitable access to essential medicines worldwide by challenging high drug prices and restrictive pharmaceutical policies.
-
A.
340B Drug Pricing Program
The 340B Drug Pricing Program is a U.S. federal initiative that requires drug manufacturers to provide outpatient medications to eligible healthcare organizations at significantly reduced prices to support care for underserved patients.
-
B.
World Health Organization Model List of Essential Medicines
The World Health Organization Model List of Essential Medicines is a periodically updated catalog of the most effective, safe, and cost-efficient medicines deemed essential for meeting the priority health needs of populations worldwide.
-
C.
Therapeutics for Rare and Neglected Diseases program
The Therapeutics for Rare and Neglected Diseases program is a U.S. government initiative that accelerates the discovery and development of new treatments for rare and underserved diseases that lack adequate commercial investment.
-
D.
Partners In Health
Partners In Health is a global health and social justice organization that delivers high-quality medical care to impoverished communities around the world and advocates for equitable health systems.
-
E.
Medicaid Drug Rebate Program
The Medicaid Drug Rebate Program is a U.S. federal initiative that requires drug manufacturers to provide rebates to state Medicaid programs in exchange for Medicaid coverage of their outpatient prescription drugs, helping control costs for the program.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d381a94c1881908fc38fc263d9b9c2 |
completed | April 6, 2026, 9:49 a.m. |
| NER | Named-entity recognition | batch_69d4d27033c081908721f6f8568059f2 |
completed | April 7, 2026, 9:46 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69d6f80c25888190a3e8a2c513df7043 |
completed | April 9, 2026, 12:51 a.m. |
| NEDg | Description generation | batch_69d6fcaca55c81908a48ac2a0ce24b85 |
completed | April 9, 2026, 1:11 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69d6fd772bc08190bf270f5fc767fb29 |
completed | April 9, 2026, 1:14 a.m. |
Created at: April 6, 2026, 11:34 a.m.